Summary

The global IgG2a Antibody market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
IgG2a Antibody is a subclass of the IgG antibody, which is one of the major classes of antibodies produced by the immune system. IgG2a antibodies are involved in immune responses by recognizing and neutralizing foreign substances such as bacteria and viruses. This subclass of IgG antibodies is known for its ability to activate complement, a part of the immune system that helps to destroy pathogens. IgG2a antibodies are commonly used in research and diagnostic applications to study immune responses and detect the presence of certain diseases.
The industry trend for IgG2a Antibody has seen a rise in recent years due to its importance in immunology research and diagnostics. These antibodies are essential for understanding the humoral immune response and have significant in the development of vaccines, therapeutic antibodies, and diagnostic tests. The potential for IgG2a Antibody in personalized medicine and precision diagnostics is expected to the industry trend forward. As the field of immunology continues to advance, the use of IgG2a Antibody in research and potential clinical applications is likely to remain strong.
The global IgG2a Antibody market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Bio-Rad
Bio X Cell
Aviva Systems Biology
R&D Systems
Biorbyt
RayBiotech
MyBioSource
BioLegend
Thermo Fisher Scientific
Novus Biologicals
SouthernBiotech
Mabtech
Cell Sciences
American Research Products
Abeomics
LI-COR Biosciences
RevMAb Biosciences
OriGene Technologies
Proteintech Group
QED Bioscience
Miltenyi Biotec
Absolute Antibody
Synaptic Systems
Bethyl Laboratories
Tonbo Biosciences
LSBio
Merck
NSJ Bioreagents
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of IgG2a Antibody market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the IgG2a Antibody value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IgG2a Antibody Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global IgG2a Antibody Market Share by Revenue, by Region (2021-2026)
2.4 Global IgG2a Antibody Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America IgG2a Antibody Market Size and Prospective (2021-2032)
2.5.2 Europe IgG2a Antibody Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific IgG2a Antibody Market Size and Prospective (2021-2032)
2.5.4 Latin America IgG2a Antibody Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa IgG2a Antibody Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global IgG2a Antibody Historical Market Size by Type (2021-2026)
3.2 Global IgG2a Antibody Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of IgG2a Antibody
4 Breakdown Data by Application
4.1 Global IgG2a Antibody Historical Market Size by Application (2021-2026)
4.2 Global IgG2a Antibody Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in IgG2a Antibody Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top IgG2a Antibody Players by Revenue (2021-2026)
5.1.2 Global IgG2a Antibody Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by IgG2a Antibody Revenue
5.4 Global IgG2a Antibody Market Concentration Analysis
5.4.1 Global IgG2a Antibody Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by IgG2a Antibody Revenue in 2025
5.5 Global Key Players of IgG2a Antibody Head Offices and Areas Served
5.6 Global Key Players of IgG2a Antibody, Product and Application
5.7 Global Key Players of IgG2a Antibody, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America IgG2a Antibody Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America IgG2a Antibody Market Size by Type (2021-2026)
6.1.2.2 North America IgG2a Antibody Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America IgG2a Antibody Market Size by Application (2021-2026)
6.1.3.2 North America IgG2a Antibody Market Share by Application (2021-2026)
6.1.4 North America IgG2a Antibody Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe IgG2a Antibody Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe IgG2a Antibody Market Size by Type (2021-2026)
6.2.2.2 Europe IgG2a Antibody Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe IgG2a Antibody Market Size by Application (2021-2026)
6.2.3.2 Europe IgG2a Antibody Market Share by Application (2021-2026)
6.2.4 Europe IgG2a Antibody Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific IgG2a Antibody Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific IgG2a Antibody Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific IgG2a Antibody Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific IgG2a Antibody Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific IgG2a Antibody Market Share by Application (2021-2026)
6.3.4 Asia-Pacific IgG2a Antibody Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America IgG2a Antibody Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America IgG2a Antibody Market Size by Type (2021-2026)
6.4.2.2 Latin America IgG2a Antibody Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America IgG2a Antibody Market Size by Application (2021-2026)
6.4.3.2 Latin America IgG2a Antibody Market Share by Application (2021-2026)
6.4.4 Latin America IgG2a Antibody Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa IgG2a Antibody Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa IgG2a Antibody Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa IgG2a Antibody Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa IgG2a Antibody Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa IgG2a Antibody Market Share by Application (2021-2026)
6.5.4 Middle East & Africa IgG2a Antibody Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Bio-Rad
7.1.1 Bio-Rad Company Details
7.1.2 Bio-Rad Business Overview
7.1.3 Bio-Rad IgG2a Antibody Introduction
7.1.4 Bio-Rad Revenue in IgG2a Antibody Business (2021-2026)
7.1.5 Bio-Rad Recent Development
7.2 Bio X Cell
7.2.1 Bio X Cell Company Details
7.2.2 Bio X Cell Business Overview
7.2.3 Bio X Cell IgG2a Antibody Introduction
7.2.4 Bio X Cell Revenue in IgG2a Antibody Business (2021-2026)
7.2.5 Bio X Cell Recent Development
7.3 Aviva Systems Biology
7.3.1 Aviva Systems Biology Company Details
7.3.2 Aviva Systems Biology Business Overview
7.3.3 Aviva Systems Biology IgG2a Antibody Introduction
7.3.4 Aviva Systems Biology Revenue in IgG2a Antibody Business (2021-2026)
7.3.5 Aviva Systems Biology Recent Development
7.4 R&D Systems
7.4.1 R&D Systems Company Details
7.4.2 R&D Systems Business Overview
7.4.3 R&D Systems IgG2a Antibody Introduction
7.4.4 R&D Systems Revenue in IgG2a Antibody Business (2021-2026)
7.4.5 R&D Systems Recent Development
7.5 Biorbyt
7.5.1 Biorbyt Company Details
7.5.2 Biorbyt Business Overview
7.5.3 Biorbyt IgG2a Antibody Introduction
7.5.4 Biorbyt Revenue in IgG2a Antibody Business (2021-2026)
7.5.5 Biorbyt Recent Development
7.6 RayBiotech
7.6.1 RayBiotech Company Details
7.6.2 RayBiotech Business Overview
7.6.3 RayBiotech IgG2a Antibody Introduction
7.6.4 RayBiotech Revenue in IgG2a Antibody Business (2021-2026)
7.6.5 RayBiotech Recent Development
7.7 MyBioSource
7.7.1 MyBioSource Company Details
7.7.2 MyBioSource Business Overview
7.7.3 MyBioSource IgG2a Antibody Introduction
7.7.4 MyBioSource Revenue in IgG2a Antibody Business (2021-2026)
7.7.5 MyBioSource Recent Development
7.8 BioLegend
7.8.1 BioLegend Company Details
7.8.2 BioLegend Business Overview
7.8.3 BioLegend IgG2a Antibody Introduction
7.8.4 BioLegend Revenue in IgG2a Antibody Business (2021-2026)
7.8.5 BioLegend Recent Development
7.9 Thermo Fisher Scientific
7.9.1 Thermo Fisher Scientific Company Details
7.9.2 Thermo Fisher Scientific Business Overview
7.9.3 Thermo Fisher Scientific IgG2a Antibody Introduction
7.9.4 Thermo Fisher Scientific Revenue in IgG2a Antibody Business (2021-2026)
7.9.5 Thermo Fisher Scientific Recent Development
7.10 Novus Biologicals
7.10.1 Novus Biologicals Company Details
7.10.2 Novus Biologicals Business Overview
7.10.3 Novus Biologicals IgG2a Antibody Introduction
7.10.4 Novus Biologicals Revenue in IgG2a Antibody Business (2021-2026)
7.10.5 Novus Biologicals Recent Development
7.11 SouthernBiotech
7.11.1 SouthernBiotech Company Details
7.11.2 SouthernBiotech Business Overview
7.11.3 SouthernBiotech IgG2a Antibody Introduction
7.11.4 SouthernBiotech Revenue in IgG2a Antibody Business (2021-2026)
7.11.5 SouthernBiotech Recent Development
7.12 Mabtech
7.12.1 Mabtech Company Details
7.12.2 Mabtech Business Overview
7.12.3 Mabtech IgG2a Antibody Introduction
7.12.4 Mabtech Revenue in IgG2a Antibody Business (2021-2026)
7.12.5 Mabtech Recent Development
7.13 Cell Sciences
7.13.1 Cell Sciences Company Details
7.13.2 Cell Sciences Business Overview
7.13.3 Cell Sciences IgG2a Antibody Introduction
7.13.4 Cell Sciences Revenue in IgG2a Antibody Business (2021-2026)
7.13.5 Cell Sciences Recent Development
7.14 American Research Products
7.14.1 American Research Products Company Details
7.14.2 American Research Products Business Overview
7.14.3 American Research Products IgG2a Antibody Introduction
7.14.4 American Research Products Revenue in IgG2a Antibody Business (2021-2026)
7.14.5 American Research Products Recent Development
7.15 Abeomics
7.15.1 Abeomics Company Details
7.15.2 Abeomics Business Overview
7.15.3 Abeomics IgG2a Antibody Introduction
7.15.4 Abeomics Revenue in IgG2a Antibody Business (2021-2026)
7.15.5 Abeomics Recent Development
7.16 LI-COR Biosciences
7.16.1 LI-COR Biosciences Company Details
7.16.2 LI-COR Biosciences Business Overview
7.16.3 LI-COR Biosciences IgG2a Antibody Introduction
7.16.4 LI-COR Biosciences Revenue in IgG2a Antibody Business (2021-2026)
7.16.5 LI-COR Biosciences Recent Development
7.17 RevMAb Biosciences
7.17.1 RevMAb Biosciences Company Details
7.17.2 RevMAb Biosciences Business Overview
7.17.3 RevMAb Biosciences IgG2a Antibody Introduction
7.17.4 RevMAb Biosciences Revenue in IgG2a Antibody Business (2021-2026)
7.17.5 RevMAb Biosciences Recent Development
7.18 OriGene Technologies
7.18.1 OriGene Technologies Company Details
7.18.2 OriGene Technologies Business Overview
7.18.3 OriGene Technologies IgG2a Antibody Introduction
7.18.4 OriGene Technologies Revenue in IgG2a Antibody Business (2021-2026)
7.18.5 OriGene Technologies Recent Development
7.19 Proteintech Group
7.19.1 Proteintech Group Company Details
7.19.2 Proteintech Group Business Overview
7.19.3 Proteintech Group IgG2a Antibody Introduction
7.19.4 Proteintech Group Revenue in IgG2a Antibody Business (2021-2026)
7.19.5 Proteintech Group Recent Development
7.20 QED Bioscience
7.20.1 QED Bioscience Company Details
7.20.2 QED Bioscience Business Overview
7.20.3 QED Bioscience IgG2a Antibody Introduction
7.20.4 QED Bioscience Revenue in IgG2a Antibody Business (2021-2026)
7.20.5 QED Bioscience Recent Development
7.21 Miltenyi Biotec
7.21.1 Miltenyi Biotec Company Details
7.21.2 Miltenyi Biotec Business Overview
7.21.3 Miltenyi Biotec IgG2a Antibody Introduction
7.21.4 Miltenyi Biotec Revenue in IgG2a Antibody Business (2021-2026)
7.21.5 Miltenyi Biotec Recent Development
7.22 Absolute Antibody
7.22.1 Absolute Antibody Company Details
7.22.2 Absolute Antibody Business Overview
7.22.3 Absolute Antibody IgG2a Antibody Introduction
7.22.4 Absolute Antibody Revenue in IgG2a Antibody Business (2021-2026)
7.22.5 Absolute Antibody Recent Development
7.23 Synaptic Systems
7.23.1 Synaptic Systems Company Details
7.23.2 Synaptic Systems Business Overview
7.23.3 Synaptic Systems IgG2a Antibody Introduction
7.23.4 Synaptic Systems Revenue in IgG2a Antibody Business (2021-2026)
7.23.5 Synaptic Systems Recent Development
7.24 Bethyl Laboratories
7.24.1 Bethyl Laboratories Company Details
7.24.2 Bethyl Laboratories Business Overview
7.24.3 Bethyl Laboratories IgG2a Antibody Introduction
7.24.4 Bethyl Laboratories Revenue in IgG2a Antibody Business (2021-2026)
7.24.5 Bethyl Laboratories Recent Development
7.25 Tonbo Biosciences
7.25.1 Tonbo Biosciences Company Details
7.25.2 Tonbo Biosciences Business Overview
7.25.3 Tonbo Biosciences IgG2a Antibody Introduction
7.25.4 Tonbo Biosciences Revenue in IgG2a Antibody Business (2021-2026)
7.25.5 Tonbo Biosciences Recent Development
7.26 LSBio
7.26.1 LSBio Company Details
7.26.2 LSBio Business Overview
7.26.3 LSBio IgG2a Antibody Introduction
7.26.4 LSBio Revenue in IgG2a Antibody Business (2021-2026)
7.26.5 LSBio Recent Development
7.27 Merck
7.27.1 Merck Company Details
7.27.2 Merck Business Overview
7.27.3 Merck IgG2a Antibody Introduction
7.27.4 Merck Revenue in IgG2a Antibody Business (2021-2026)
7.27.5 Merck Recent Development
7.28 NSJ Bioreagents
7.28.1 NSJ Bioreagents Company Details
7.28.2 NSJ Bioreagents Business Overview
7.28.3 NSJ Bioreagents IgG2a Antibody Introduction
7.28.4 NSJ Bioreagents Revenue in IgG2a Antibody Business (2021-2026)
7.28.5 NSJ Bioreagents Recent Development
8 IgG2a Antibody Market Dynamics
8.1 IgG2a Antibody Industry Trends
8.2 IgG2a Antibody Market Drivers
8.3 IgG2a Antibody Market Challenges
8.4 IgG2a Antibody Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global IgG2a Antibody Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global IgG2a Antibody Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market IgG2a Antibody Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global IgG2a Antibody Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global IgG2a Antibody Revenue Share by Region (2021-2026)
Table 6. Global IgG2a Antibody Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global IgG2a Antibody Revenue Share Forecast by Region (2027-2032)
Table 8. Global IgG2a Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global IgG2a Antibody Market Share by Revenue, by Type (2021-2026)
Table 10. Global IgG2a Antibody Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global IgG2a Antibody Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global IgG2a Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global IgG2a Antibody Market Share by Revenue, by Application (2021-2026)
Table 15. Global IgG2a Antibody Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global IgG2a Antibody Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in IgG2a Antibody Applications
Table 18. Global IgG2a Antibody Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global IgG2a Antibody Market Share by Players (2021-2026)
Table 20. Global Top IgG2a Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgG2a Antibody as of 2025)
Table 21. Ranking of Global Top IgG2a Antibody Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by IgG2a Antibody Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of IgG2a Antibody, Headquarters and Area Served
Table 24. Global Key Players of IgG2a Antibody, Product and Application
Table 25. Global Key Players of IgG2a Antibody, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America IgG2a Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America IgG2a Antibody Market Share by Revenue, by Company (2021-2026)
Table 29. North America IgG2a Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America IgG2a Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe IgG2a Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe IgG2a Antibody Market Share by Revenue, by Company (2021-2026)
Table 33. Europe IgG2a Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe IgG2a Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific IgG2a Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific IgG2a Antibody Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific IgG2a Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific IgG2a Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America IgG2a Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America IgG2a Antibody Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America IgG2a Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America IgG2a Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa IgG2a Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa IgG2a Antibody Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa IgG2a Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa IgG2a Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 47. Bio-Rad Company Details
Table 48. Bio-Rad Business Overview
Table 49. Bio-Rad IgG2a Antibody Product
Table 50. Bio-Rad Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 51. Bio-Rad Recent Development
Table 52. Bio X Cell Company Details
Table 53. Bio X Cell Business Overview
Table 54. Bio X Cell IgG2a Antibody Product
Table 55. Bio X Cell Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 56. Bio X Cell Recent Development
Table 57. Aviva Systems Biology Company Details
Table 58. Aviva Systems Biology Business Overview
Table 59. Aviva Systems Biology IgG2a Antibody Product
Table 60. Aviva Systems Biology Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 61. Aviva Systems Biology Recent Development
Table 62. R&D Systems Company Details
Table 63. R&D Systems Business Overview
Table 64. R&D Systems IgG2a Antibody Product
Table 65. R&D Systems Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 66. R&D Systems Recent Development
Table 67. Biorbyt Company Details
Table 68. Biorbyt Business Overview
Table 69. Biorbyt IgG2a Antibody Product
Table 70. Biorbyt Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 71. Biorbyt Recent Development
Table 72. RayBiotech Company Details
Table 73. RayBiotech Business Overview
Table 74. RayBiotech IgG2a Antibody Product
Table 75. RayBiotech Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 76. RayBiotech Recent Development
Table 77. MyBioSource Company Details
Table 78. MyBioSource Business Overview
Table 79. MyBioSource IgG2a Antibody Product
Table 80. MyBioSource Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 81. MyBioSource Recent Development
Table 82. BioLegend Company Details
Table 83. BioLegend Business Overview
Table 84. BioLegend IgG2a Antibody Product
Table 85. BioLegend Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 86. BioLegend Recent Development
Table 87. Thermo Fisher Scientific Company Details
Table 88. Thermo Fisher Scientific Business Overview
Table 89. Thermo Fisher Scientific IgG2a Antibody Product
Table 90. Thermo Fisher Scientific Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 91. Thermo Fisher Scientific Recent Development
Table 92. Novus Biologicals Company Details
Table 93. Novus Biologicals Business Overview
Table 94. Novus Biologicals IgG2a Antibody Product
Table 95. Novus Biologicals Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 96. Novus Biologicals Recent Development
Table 97. SouthernBiotech Company Details
Table 98. SouthernBiotech Business Overview
Table 99. SouthernBiotech IgG2a Antibody Product
Table 100. SouthernBiotech Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 101. SouthernBiotech Recent Development
Table 102. Mabtech Company Details
Table 103. Mabtech Business Overview
Table 104. Mabtech IgG2a Antibody Product
Table 105. Mabtech Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 106. Mabtech Recent Development
Table 107. Cell Sciences Company Details
Table 108. Cell Sciences Business Overview
Table 109. Cell Sciences IgG2a Antibody Product
Table 110. Cell Sciences Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 111. Cell Sciences Recent Development
Table 112. American Research Products Company Details
Table 113. American Research Products Business Overview
Table 114. American Research Products IgG2a Antibody Product
Table 115. American Research Products Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 116. American Research Products Recent Development
Table 117. Abeomics Company Details
Table 118. Abeomics Business Overview
Table 119. Abeomics IgG2a Antibody Product
Table 120. Abeomics Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 121. Abeomics Recent Development
Table 122. LI-COR Biosciences Company Details
Table 123. LI-COR Biosciences Business Overview
Table 124. LI-COR Biosciences IgG2a Antibody Product
Table 125. LI-COR Biosciences Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 126. LI-COR Biosciences Recent Development
Table 127. RevMAb Biosciences Company Details
Table 128. RevMAb Biosciences Business Overview
Table 129. RevMAb Biosciences IgG2a Antibody Product
Table 130. RevMAb Biosciences Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 131. RevMAb Biosciences Recent Development
Table 132. OriGene Technologies Company Details
Table 133. OriGene Technologies Business Overview
Table 134. OriGene Technologies IgG2a Antibody Product
Table 135. OriGene Technologies Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 136. OriGene Technologies Recent Development
Table 137. Proteintech Group Company Details
Table 138. Proteintech Group Business Overview
Table 139. Proteintech Group IgG2a Antibody Product
Table 140. Proteintech Group Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 141. Proteintech Group Recent Development
Table 142. QED Bioscience Company Details
Table 143. QED Bioscience Business Overview
Table 144. QED Bioscience IgG2a Antibody Product
Table 145. QED Bioscience Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 146. QED Bioscience Recent Development
Table 147. Miltenyi Biotec Company Details
Table 148. Miltenyi Biotec Business Overview
Table 149. Miltenyi Biotec IgG2a Antibody Product
Table 150. Miltenyi Biotec Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 151. Miltenyi Biotec Recent Development
Table 152. Absolute Antibody Company Details
Table 153. Absolute Antibody Business Overview
Table 154. Absolute Antibody IgG2a Antibody Product
Table 155. Absolute Antibody Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 156. Absolute Antibody Recent Development
Table 157. Synaptic Systems Company Details
Table 158. Synaptic Systems Business Overview
Table 159. Synaptic Systems IgG2a Antibody Product
Table 160. Synaptic Systems Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 161. Synaptic Systems Recent Development
Table 162. Bethyl Laboratories Company Details
Table 163. Bethyl Laboratories Business Overview
Table 164. Bethyl Laboratories IgG2a Antibody Product
Table 165. Bethyl Laboratories Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 166. Bethyl Laboratories Recent Development
Table 167. Tonbo Biosciences Company Details
Table 168. Tonbo Biosciences Business Overview
Table 169. Tonbo Biosciences IgG2a Antibody Product
Table 170. Tonbo Biosciences Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 171. Tonbo Biosciences Recent Development
Table 172. LSBio Company Details
Table 173. LSBio Business Overview
Table 174. LSBio IgG2a Antibody Product
Table 175. LSBio Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 176. LSBio Recent Development
Table 177. Merck Company Details
Table 178. Merck Business Overview
Table 179. Merck IgG2a Antibody Product
Table 180. Merck Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 181. Merck Recent Development
Table 182. NSJ Bioreagents Company Details
Table 183. NSJ Bioreagents Business Overview
Table 184. NSJ Bioreagents IgG2a Antibody Product
Table 185. NSJ Bioreagents Revenue in IgG2a Antibody Business (2021-2026) & (US$ Million)
Table 186. NSJ Bioreagents Recent Development
Table 187. IgG2a Antibody Market Trends
Table 188. IgG2a Antibody Market Drivers
Table 189. IgG2a Antibody Market Challenges
Table 190. IgG2a Antibody Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources


List of Figures
Figure 1. IgG2a Antibody Product Picture
Figure 2. Global IgG2a Antibody Market Share by Type: 2025 vs 2032
Figure 3. Monoclonal Antibody Features
Figure 4. Polyclonal Antibody Features
Figure 5. Global IgG2a Antibody Market Share by Application: 2025 vs 2032
Figure 6. Biotechnology
Figure 7. Medical
Figure 8. University
Figure 9. Others
Figure 10. IgG2a Antibody Report Years Considered
Figure 11. Global IgG2a Antibody Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 12. Global IgG2a Antibody Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global IgG2a Antibody Market Share by Revenue, by Region: 2021 vs 2025
Figure 14. North America IgG2a Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Europe IgG2a Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Asia-Pacific IgG2a Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Latin America IgG2a Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Middle East & Africa IgG2a Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Global IgG2a Antibody Market Share by Players in 2025
Figure 20. Global Top IgG2a Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgG2a Antibody as of 2025)
Figure 21. The Top 10 and 5 Players Market Share by IgG2a Antibody Revenue in 2025
Figure 22. North America IgG2a Antibody Market Share by Type (2021-2026)
Figure 23. North America IgG2a Antibody Market Share by Application (2021-2026)
Figure 24. Europe IgG2a Antibody Market Share by Type (2021-2026)
Figure 25. Europe IgG2a Antibody Market Share by Application (2021-2026)
Figure 26. Asia-Pacific IgG2a Antibody Market Share by Type (2021-2026)
Figure 27. Asia-Pacific IgG2a Antibody Market Share by Application (2021-2026)
Figure 28. Latin America IgG2a Antibody Market Share by Type (2021-2026)
Figure 29. Latin America IgG2a Antibody Market Share by Application (2021-2026)
Figure 30. Middle East & Africa IgG2a Antibody Market Share by Type (2021-2026)
Figure 31. Middle East & Africa IgG2a Antibody Market Share by Application (2021-2026)
Figure 32. Bio-Rad Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 33. Bio X Cell Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 34. Aviva Systems Biology Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 35. R&D Systems Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 36. Biorbyt Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 37. RayBiotech Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 38. MyBioSource Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 39. BioLegend Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 40. Thermo Fisher Scientific Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 41. Novus Biologicals Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 42. SouthernBiotech Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 43. Mabtech Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 44. Cell Sciences Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 45. American Research Products Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 46. Abeomics Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 47. LI-COR Biosciences Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 48. RevMAb Biosciences Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 49. OriGene Technologies Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 50. Proteintech Group Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 51. QED Bioscience Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 52. Miltenyi Biotec Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 53. Absolute Antibody Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 54. Synaptic Systems Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 55. Bethyl Laboratories Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 56. Tonbo Biosciences Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 57. LSBio Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 58. Merck Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 59. NSJ Bioreagents Revenue Growth Rate in IgG2a Antibody Business (2021-2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed